{"pmid":32449272,"title":"Lung ultrasonography in COVID-19: a gamechanger in the Stroke Unit?","text":["Lung ultrasonography in COVID-19: a gamechanger in the Stroke Unit?","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is rapidly spreading worldwide, and the WHO declared its pandemic nature on 11(th) March 2020(1) . The outbreak has hit Europe and, as of April 19, 2020, Italy has the third largest number of confirmed cases, namely a total of 175,925 cases and 23,227 deaths according to the John Hopkins University(2) . This is the largest health and economic emergency of our country since the post-war period, and many hospitals are now dedicated exclusively to COVID-19 assistance. Our University Hub Stroke Unit of Cattinara Hospital is in the northeaster Italian region of Friuli Venezia Giulia which enlisted 2,731 cases and 222 deaths at the time of writing(3) .","Eur J Neurol","Lugnan, Carlo","Tommasini, Valentina","Furlanis, Giovanni","Naccarato, Marcello","Caruso, Paola","Scali, Ilario","Buoite Stella, Alex","Ajcevic, Milos","Cillotto, Tommaso","Manganotti, Paolo","32449272"],"abstract":["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is rapidly spreading worldwide, and the WHO declared its pandemic nature on 11(th) March 2020(1) . The outbreak has hit Europe and, as of April 19, 2020, Italy has the third largest number of confirmed cases, namely a total of 175,925 cases and 23,227 deaths according to the John Hopkins University(2) . This is the largest health and economic emergency of our country since the post-war period, and many hospitals are now dedicated exclusively to COVID-19 assistance. Our University Hub Stroke Unit of Cattinara Hospital is in the northeaster Italian region of Friuli Venezia Giulia which enlisted 2,731 cases and 222 deaths at the time of writing(3) ."],"journal":"Eur J Neurol","authors":["Lugnan, Carlo","Tommasini, Valentina","Furlanis, Giovanni","Naccarato, Marcello","Caruso, Paola","Scali, Ilario","Buoite Stella, Alex","Ajcevic, Milos","Cillotto, Tommaso","Manganotti, Paolo"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449272","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/ene.14352","keywords":["covid-19","stroke unit","lung ultrasonography"],"locations":["Italy","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1667785213916217344,"score":9.490897,"similar":[{"pmid":32416370,"title":"Has COVID-19 played an unexpected \"stroke\" on the chain of survival?","text":["Has COVID-19 played an unexpected \"stroke\" on the chain of survival?","BACKGROUND: The COVID-19 pandemics required several changes in stroke management and it may have influenced some clinical or functional characteristics. We aimed to evaluate the effects of the COVID-19 pandemics on stroke management during the first month of Italy lockdown. In addition, we described the emergency structured pathway adopted by an Italian University Hub Stroke Unit in the cross-border Italy-Slovenia area. METHODS: We analyzed admitted patients' clinical features and outcomes between 9th March 2020 and 9th April 2020 (first month of lockdown), and compared them with patients admitted during the same period in 2019. RESULTS: Total admissions experienced a reduction of 45% during the lockdown compared to the same period in 2019 (16 vs 29, respectively), as well as a higher prevalence of severe stroke (NIHSS>10) at admission (n = 8, 50% vs n = 8, 28%). A dramatic prevalence of stroke of unknown symptom onset was observed in 2020 (n = 8, 50% vs n = 3, 10%). During lockdown, worse functional and independence outcomes were found, despite the similar proportion of reperfused patients. Similar 'symptoms alert-to-admission' and 'door-to-treatment' times were observed. During lockdown hospitalization was shorter and fewer patients completed the stroke work-up. CONCLUSION: In conclusion, the adopted strategies for stroke management during the COVID-19 emergency have suggested being effective, while suffering a reduced and delayed reporting of symptoms. Therefore, we recommend raising awareness among the population against possible stroke symptoms onset. Thus, think F.A.S.T. and do not stay-at-home at all costs.","J Neurol Sci","Naccarato, Marcello","Scali, Ilario","Olivo, Sasha","Ajcevic, Milos","Buoite Stella, Alex","Furlanis, Giovanni","Lugnan, Carlo","Caruso, Paola","Peratoner, Alberto","Cominotto, Franco","Manganotti, Paolo","32416370"],"abstract":["BACKGROUND: The COVID-19 pandemics required several changes in stroke management and it may have influenced some clinical or functional characteristics. We aimed to evaluate the effects of the COVID-19 pandemics on stroke management during the first month of Italy lockdown. In addition, we described the emergency structured pathway adopted by an Italian University Hub Stroke Unit in the cross-border Italy-Slovenia area. METHODS: We analyzed admitted patients' clinical features and outcomes between 9th March 2020 and 9th April 2020 (first month of lockdown), and compared them with patients admitted during the same period in 2019. RESULTS: Total admissions experienced a reduction of 45% during the lockdown compared to the same period in 2019 (16 vs 29, respectively), as well as a higher prevalence of severe stroke (NIHSS>10) at admission (n = 8, 50% vs n = 8, 28%). A dramatic prevalence of stroke of unknown symptom onset was observed in 2020 (n = 8, 50% vs n = 3, 10%). During lockdown, worse functional and independence outcomes were found, despite the similar proportion of reperfused patients. Similar 'symptoms alert-to-admission' and 'door-to-treatment' times were observed. During lockdown hospitalization was shorter and fewer patients completed the stroke work-up. CONCLUSION: In conclusion, the adopted strategies for stroke management during the COVID-19 emergency have suggested being effective, while suffering a reduced and delayed reporting of symptoms. Therefore, we recommend raising awareness among the population against possible stroke symptoms onset. Thus, think F.A.S.T. and do not stay-at-home at all costs."],"journal":"J Neurol Sci","authors":["Naccarato, Marcello","Scali, Ilario","Olivo, Sasha","Ajcevic, Milos","Buoite Stella, Alex","Furlanis, Giovanni","Lugnan, Carlo","Caruso, Paola","Peratoner, Alberto","Cominotto, Franco","Manganotti, Paolo"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416370","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jns.2020.116889","keywords":["covid","coronavirus","ischemic stroke","outcome","stroke unit"],"locations":["Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666991242727129088,"score":214.08531},{"pmid":32270359,"pmcid":"PMC7141930","title":"Acute stroke management pathway during Coronavirus-19 pandemic.","text":["Acute stroke management pathway during Coronavirus-19 pandemic.","Since the outbreak of the COVID-19 epidemic which in our region, Veneto (Italy), dates back to February, we were confronted with several challenges, but with a constant aim of keeping our Stroke Unit COVID-free. For this reason, in addition to creating a dedicated hot-spot as a pre-triage just outside the Emergency Department, together with the Neuroradiology Unit we obtained a mobile CT unit that could be used by COVID-positive or COVID-suspected patients. Furthermore, thanks to the collaboration with colleagues from different specialties (Infectious Disease, Internal Medicine, Intensive Care, Emergency Medicine), dedicated areas for COVID patients were activated. This led to a substantial change of our acute stoke management pathway. As the number of COVID patients increased, and the WHO declared a state of pandemic, this new stroke pathway has been fully tested. We would like to share our experience and send a clear message to keep a high attention on stroke as an emergency condition, because we have observed a decreased number of patients with minor strokes and TIAs, longer onset-to-door and door-to-treatment times for major strokes, and a reduced number of transfers from spokes. We strongly believe that the general population and family doctors are rightly focused on COVID. However, to remain at home with stroke symptoms does not mean to \"stay safe at home\".","Neurol Sci","Baracchini, Claudio","Pieroni, Alessio","Viaro, Federica","Cianci, Vito","Cattelan, Anna M","Tiberio, Ivo","Munari, Marina","Causin, Francesco","32270359"],"abstract":["Since the outbreak of the COVID-19 epidemic which in our region, Veneto (Italy), dates back to February, we were confronted with several challenges, but with a constant aim of keeping our Stroke Unit COVID-free. For this reason, in addition to creating a dedicated hot-spot as a pre-triage just outside the Emergency Department, together with the Neuroradiology Unit we obtained a mobile CT unit that could be used by COVID-positive or COVID-suspected patients. Furthermore, thanks to the collaboration with colleagues from different specialties (Infectious Disease, Internal Medicine, Intensive Care, Emergency Medicine), dedicated areas for COVID patients were activated. This led to a substantial change of our acute stoke management pathway. As the number of COVID patients increased, and the WHO declared a state of pandemic, this new stroke pathway has been fully tested. We would like to share our experience and send a clear message to keep a high attention on stroke as an emergency condition, because we have observed a decreased number of patients with minor strokes and TIAs, longer onset-to-door and door-to-treatment times for major strokes, and a reduced number of transfers from spokes. We strongly believe that the general population and family doctors are rightly focused on COVID. However, to remain at home with stroke symptoms does not mean to \"stay safe at home\"."],"journal":"Neurol Sci","authors":["Baracchini, Claudio","Pieroni, Alessio","Viaro, Federica","Cianci, Vito","Cattelan, Anna M","Tiberio, Ivo","Munari, Marina","Causin, Francesco"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270359","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s10072-020-04375-9","keywords":["acute stroke","covid-19","coronavirus","stroke unit"],"topics":["Prevention"],"weight":1,"_version_":1666138491857141761,"score":183.96008},{"pmid":32445935,"title":"Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy.","text":["Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy.","OBJECTIVE: The aim of this study is to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) among adult patients treated with biologic agents or small molecules for chronic inflammatory rheumatic diseases, in particular chronic inflammatory arthritides. METHODS: To this end, a population-based study, in the province of Udine (466,700 inhabitants, with age > 15 years old, Friuli Venezia Giulia region, Italy) was planned. The primary outcome was the prevalence of COVID-19 in the first two months of the outbreak. All the rheumatic patients treated with biologic agents or small molecules in the last 6 months in our province were included (N=1051). RESULTS: From February 29 to April 25, 2020, 4 adult patients (4/1051, i.e. 3.8/1000, 95% Confidence Interval 1.5-9.7/1000) were registered as swab test positive by PCR for COVID-19. Overall, a total of 47/1051 (4,5%) cases were tested for COVID-19 by PCR in the same period, and 15 of them due to symptoms compatible with COVID-19. In the general population, the prevalence was 937 cases/466700 (2/1000, 95% Confidence Interval 1.9-2.1/1000, p value=0.33, chi square test), and 20,179/466,700 (4.3%) swab tests for COVID-19 were performed.. CONCLUSION: The risk of COVID-19 in rheumatic patients under biologic agents or small molecules does not appear different from that observed in the general population. Patients should be informed to safely proceed with their treatment and follow the rules for self-protection to COVID-19.","Joint Bone Spine","Quartuccio, Luca","Valent, Francesca","Pasut, Enrico","Tascini, Carlo","Vita, Salvatore De","32445935"],"abstract":["OBJECTIVE: The aim of this study is to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) among adult patients treated with biologic agents or small molecules for chronic inflammatory rheumatic diseases, in particular chronic inflammatory arthritides. METHODS: To this end, a population-based study, in the province of Udine (466,700 inhabitants, with age > 15 years old, Friuli Venezia Giulia region, Italy) was planned. The primary outcome was the prevalence of COVID-19 in the first two months of the outbreak. All the rheumatic patients treated with biologic agents or small molecules in the last 6 months in our province were included (N=1051). RESULTS: From February 29 to April 25, 2020, 4 adult patients (4/1051, i.e. 3.8/1000, 95% Confidence Interval 1.5-9.7/1000) were registered as swab test positive by PCR for COVID-19. Overall, a total of 47/1051 (4,5%) cases were tested for COVID-19 by PCR in the same period, and 15 of them due to symptoms compatible with COVID-19. In the general population, the prevalence was 937 cases/466700 (2/1000, 95% Confidence Interval 1.9-2.1/1000, p value=0.33, chi square test), and 20,179/466,700 (4.3%) swab tests for COVID-19 were performed.. CONCLUSION: The risk of COVID-19 in rheumatic patients under biologic agents or small molecules does not appear different from that observed in the general population. Patients should be informed to safely proceed with their treatment and follow the rules for self-protection to COVID-19."],"journal":"Joint Bone Spine","authors":["Quartuccio, Luca","Valent, Francesca","Pasut, Enrico","Tascini, Carlo","Vita, Salvatore De"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445935","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jbspin.2020.05.003","keywords":["covid-19","biologic","coronavirus","rheumatic disease","rheumatoid arthritis","small molecule","tumor necrosis factor"],"locations":["Italy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667600475830091776,"score":167.5088},{"pmid":32468695,"title":"COVID-19: Moving beyond the pandemic.","text":["COVID-19: Moving beyond the pandemic.","Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is the cause of COVID-19. As of April 11th, 2020, there were almost 2 million cases of COVID-19 internationally and over 100,000 deaths (John Hopkins University, 2020). There has been significant effort to increase hospital and healthcare capacity to reduce the number of fatalities associated with this global pandemic (Choi & Logsdon 2020).","J Adv Nurs","McPeake, Joanne","Pattison, Natalie","32468695"],"abstract":["Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is the cause of COVID-19. As of April 11th, 2020, there were almost 2 million cases of COVID-19 internationally and over 100,000 deaths (John Hopkins University, 2020). There has been significant effort to increase hospital and healthcare capacity to reduce the number of fatalities associated with this global pandemic (Choi & Logsdon 2020)."],"journal":"J Adv Nurs","authors":["McPeake, Joanne","Pattison, Natalie"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468695","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jan.14438","weight":0,"_version_":1668420887084269568,"score":154.45703},{"pmid":32287518,"pmcid":"PMC7139246","title":"Rapid surveillance of COVID-19 in the United States using a prospective space-time scan statistic: Detecting and evaluating emerging clusters.","text":["Rapid surveillance of COVID-19 in the United States using a prospective space-time scan statistic: Detecting and evaluating emerging clusters.","Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China in December 2019, and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a pandemic with an estimated death rate between 1% and 5%; and an estimated R 0 between 2.2 and 6.7 according to various sources. As of March 28th, 2020, there were over 649,000 confirmed cases and 30,249 total deaths, globally. In the United States, there were over 115,500 cases and 1891 deaths and this number is likely to increase rapidly. It is critical to detect clusters of COVID-19 to better allocate resources and improve decision-making as the outbreaks continue to grow. Using daily case data at the county level provided by Johns Hopkins University, we conducted a prospective spatial-temporal analysis with SaTScan. We detect statistically significant space-time clusters of COVID-19 at the county level in the U.S. between January 22nd-March 9th, 2020, and January 22nd-March 27th, 2020. The space-time prospective scan statistic detected \"active\" and emerging clusters that are present at the end of our study periods - notably, 18 more clusters were detected when adding the updated case data. These timely results can inform public health officials and decision makers about where to improve the allocation of resources, testing sites; also, where to implement stricter quarantines and travel bans. As more data becomes available, the statistic can be rerun to support timely surveillance of COVID-19, demonstrated here. Our research is the first geographic study that utilizes space-time statistics to monitor COVID-19 in the U.S.","Appl Geogr","Desjardins, M R","Hohl, A","Delmelle, E M","32287518"],"abstract":["Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China in December 2019, and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a pandemic with an estimated death rate between 1% and 5%; and an estimated R 0 between 2.2 and 6.7 according to various sources. As of March 28th, 2020, there were over 649,000 confirmed cases and 30,249 total deaths, globally. In the United States, there were over 115,500 cases and 1891 deaths and this number is likely to increase rapidly. It is critical to detect clusters of COVID-19 to better allocate resources and improve decision-making as the outbreaks continue to grow. Using daily case data at the county level provided by Johns Hopkins University, we conducted a prospective spatial-temporal analysis with SaTScan. We detect statistically significant space-time clusters of COVID-19 at the county level in the U.S. between January 22nd-March 9th, 2020, and January 22nd-March 27th, 2020. The space-time prospective scan statistic detected \"active\" and emerging clusters that are present at the end of our study periods - notably, 18 more clusters were detected when adding the updated case data. These timely results can inform public health officials and decision makers about where to improve the allocation of resources, testing sites; also, where to implement stricter quarantines and travel bans. As more data becomes available, the statistic can be rerun to support timely surveillance of COVID-19, demonstrated here. Our research is the first geographic study that utilizes space-time statistics to monitor COVID-19 in the U.S."],"journal":"Appl Geogr","authors":["Desjardins, M R","Hohl, A","Delmelle, E M"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287518","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.apgeog.2020.102202","keywords":["covid-19","disease surveillance","pandemic","satscan","space-time clusters"],"locations":["Wuhan","China","United States","USA","USA","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491328659457,"score":153.65726}]}